Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919

Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

We were interested in the recent article from Pantalone et al. (1), who reported that 23.7% of 6,973 subjects with poorly controlled type 2 diabetes (HbA1c >9%) attained HbA1c below 8% within 1 year, based on the electronic health record

Read More Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919

Response to Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919

Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

We would like to thank Larroumet et al. (1) for their interest in our article (2) and for sharing their institution’s significant experience (3). Certainly, admission to a specialized ward can durably improve the HbA1c control in patients with uncontrolled

Read More Response to Comment on Pantalone et al. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910–1919

Looking for participants to trial the impact of tailored meals and nutrition education for uncontrolled diabetes

Looking for participants to trial the impact of tailored meals and nutrition education for uncontrolled diabetes

Posted by Medivizor on Aug 23, 2020 in Diabetes mellitus | In a nutshell This study is evaluating the effect of medically tailored meals and nutrition education via tele-health for patients with uncontrolled type 2 diabetes (T2D). The outcomes include changes

Read More Looking for participants to trial the impact of tailored meals and nutrition education for uncontrolled diabetes

The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model

Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.

Research Design and MethodsStudy CohortThe EHR system at CC was used to identify a cohort of adult patients (≥18 years) with a diagnosis of T2D and who were determined to have uncontrolled T2D as reflected by an A1C >9% between

Read More The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model

Uncontrolled High Blood Pressure: Telehealth and Home Monitoring Can Help

Uncontrolled High Blood Pressure: Telehealth and Home Monitoring Can Help

by Karen Margolis, MD, MPH July 10, 2020 For most of my career, I’ve focused on cardiovascular disease and hypertension. Uncontrolled high blood pressure is the biggest factor for overall deaths in the United States. It is also is the

Read More Uncontrolled High Blood Pressure: Telehealth and Home Monitoring Can Help

Uncontrolled High Blood Pressure: Telehealth and Home Monitoring Can Help

Uncontrolled High Blood Pressure: Telehealth and Home Monitoring Can Help

by Karen Margolis, MD, MPH July 10, 2020 For most of my career, I’ve focused on cardiovascular disease and hypertension. Uncontrolled high blood pressure is the biggest factor for overall deaths in the United States. It is also is the

Read More Uncontrolled High Blood Pressure: Telehealth and Home Monitoring Can Help

Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes

Pharmacist-Provided Diabetes Education and Management in a Diverse, Medically Underserved Population

AbstractOBJECTIVE | To explore the use of premixed insulin, a glucagon-like peptide 1 (GLP-1) receptor agonist, and metformin as combination therapy for type 2 diabetes.DESIGN AND METHODS | All adult patients with type 2 diabetes who had been prescribed premixed

Read More Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes